(Q44418467)

2 December 2017

Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning (English)

1 reference

2 December 2017

Follow‐up of patients with progressive multiple myeloma undergoing allografts after reduced‐intensity conditioning (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

28 December 2023

1 reference

1

Hermann Einsele

1 reference

2 December 2017

Hans-Jörg Schäfer

2

1 reference

2 December 2017

Holger Hebart

3

1 reference

2 December 2017

Peter Bader

4

1 reference

2 December 2017

Christoph Meisner

5

1 reference

2 December 2017

Ludwig Plasswilm

6

1 reference

2 December 2017

Peter Liebisch

7

1 reference

2 December 2017

Michael Bamberg

8

1 reference

2 December 2017

Christoph Faul

9

1 reference

2 December 2017

Lothar Kanz

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

8

1 reference

based on heuristic

inferred from page(s)

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1365-2141.2003.04299.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12716363

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2141.2003.04299.x

28 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2141.2003.04299.x

28 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

British Journal of Haematology

28 December 2023

published in

1 reference

2 December 2017

121

1 reference

2 December 2017

3

1 reference

2 December 2017

411-418

1 reference

Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen

2 December 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04299.X

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04299.X

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04299.X

Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04299.X

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04299.X

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

28 December 2023

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

28 December 2023

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

28 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

28 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Diagnosis, prognosis, and standard treatment of multiple myeloma

28 December 2023

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

28 December 2023

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells

28 December 2023

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

28 December 2023

15

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation

28 December 2023

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Impact of previous high-dose therapy on outcome after allografting for multiple myeloma

28 December 2023

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

28 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome.

28 December 2023

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

1994 Consensus Conference on Acute GVHD Grading

28 December 2023

26

1 reference

https://api.crossref.org/works/10.1046/J.1365-2141.2003.04299.X

28 December 2023

Identifiers

1 reference

2 December 2017

1 reference